Puri, R., Nissen, S. E., Arsenault, B. J., St John, J., Riesmeyer, J. S., Ruotolo, G., . . . Nicholls, S. J. (2020). Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial. JAMA Cardiol.
Παραπομπή Chicago StylePuri, Rishi, et al. "Effect of C-Reactive Protein On Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial." JAMA Cardiol 2020.
Παραπομπή MLAPuri, Rishi, et al. "Effect of C-Reactive Protein On Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial." JAMA Cardiol 2020.